Daiwa Securities Group
LRMR icon

Daiwa Securities Group’s Larimar Therapeutics LRMR Stock Holding History

Daiwa Securities Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29
Closed – – 1352
2022
Q3 		$0 Hold
29
– – ﹤0.01% 1364
2022
Q2 		$0 Hold
29
– – ﹤0.01% 1397
2022
Q1 		$0 Hold
29
– – ﹤0.01% 1395
2021
Q4 		$0 Hold
29
– – ﹤0.01% 1422
2021
Q3 		$0 Hold
29
– – ﹤0.01% 1329
2021
Q2 		$0 Hold
29
– – ﹤0.01% 1279
2021
Q1 		$0 Hold
29
– – ﹤0.01% 1278
2020
Q4 		$1K Buy
+29
New +$581 ﹤0.01% 1188
2019
Q4 		– Sell
-20
Closed – – 1228
2019
Q3 		$0 Hold
20
– – ﹤0.01% 1191
2019
Q2 		$0 Hold
20
– – ﹤0.01% 1220
2019
Q1 		$1K Buy
+20
New +$1.02K ﹤0.01% 1165

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return